The authors wish to make the following correction to this paper [1].
- Error in Figure Legend
Figure 3. (c) binding avidity of OVM-sIgE (1/IC50) (nM) is incorrect and has been corrected to (c) OVM-sIgE (IC50) (nM).
Figure 4. avidity of OVM-sIgE (1/IC50) (nM) is incorrect and has been corrected to avidity of OVM-sIgE (IC50) (nM).
- Error in Figure 3c
Figure 3c title: 1/IC50 is incorrect and has been corrected to IC50.
Labels for vertical axis: I/IC50 (nM) is incorrect and has been corrected to IC50 (nM).

- Error in Figure 4
The content in the figure: 1/IC50 is incorrect and has been corrected to IC50. I/IC50 (nM) is incorrect and has been corrected to IC50 (nM).

- Error in Table 3
Line 4: I/IC50 (nM) is incorrect and has been corrected to IC50 (nM).
- Error in Table 4
Line 4: 1/IC50 (nM) is incorrect and has been corrected to IC50 (nM).
- Error in Abstract
In the 5th sentence: 1/IC50 is incorrect and has been corrected to IC50.
The authors apologize for any inconvenience caused and state that the scientific conclusions remain unaffected. The original publication has also been updated.
Reference
- Taniuchi, S.; Sakai, R.; Nishida, T.; Goma, M.; Mitomori, M.; Imaide, A.; Enomoto, M.; Nishino, M.; Okizuka, Y.; Kido, H. The Combination of Binding Avidity of Ovomucoid-Specific IgE Antibody and Specific IgG4 Antibody Can Predict Positive Outcomes of Oral Food Challenges during Stepwise Slow Oral Immunotherapy in Children with Hen’s Egg Allergy. Nutrients 2023, 15, 2770. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).